United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 16, 2026 · Filed Jul 17, 2026

On Jul 16, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$530.91 for US$5.04M under a trading plan, leaving 324,443 shares. Filed Jul 17, 2026 (Form 4).

Sold
9,500 shares
Price
US$530.91 average (US$527.31 to US$537.11)
Value
US$5.04M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 16, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Jul 16, 2026Common StockSale80US$527.31333,863Indirect
Jul 16, 2026Common StockSale1,400US$528.42332,463Indirect
Jul 16, 2026Common StockSale3,057US$529.46329,406Indirect
Jul 16, 2026Common StockSale1,924US$530.14327,482Indirect
Jul 16, 2026Common StockSale520US$532.14326,962Indirect
Jul 16, 2026Common StockSale440US$533.28326,522Indirect
Jul 16, 2026Common StockSale1,198US$534.31325,324Indirect
Jul 16, 2026Common StockSale720US$535.20324,604Indirect
Jul 16, 2026Common StockSale150US$536.29324,454Indirect
Jul 16, 2026Common StockSale11US$537.11324,443Indirect

Source

View original at SEC

Related